Zobrazeno 1 - 10
of 24
pro vyhledávání: '"XIAO-QIN LV"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2024)
For patients with cardiovascular disease, using the antidepressant escitalopram may lead to unexpected adverse events. Here, a rare repeated sinus bradycardia event due to escitalopram is first reported. In an 82-year-old female patient with cardiac
Externí odkaz:
https://doaj.org/article/f59c4b9fa49143219f39f4a4b05d0703
Autor:
Hu Li, Jia-Li Tan, Jian-Rui Li, Nan-Nan Liu, Jin-Hua Chen, Xiao-Qin Lv, Li-li Zou, Biao Dong, Zong-Gen Peng, Jian-Dong Jiang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 116, Iss , Pp 108976- (2019)
With the development of more effective direct-acting antivirals (DAAs), dual- or triple-therapy regimens represent the major strategy used to cure chronic hepatitis C virus (HCV) infection. Thus, shorter treatment duration regimens with low burden, f
Externí odkaz:
https://doaj.org/article/b7232ab276b64e0186970c9eb39614ce
Autor:
Hu Li, Jian-Rui Li, Meng-Hao Huang, Jin-Hua Chen, Xiao-Qin Lv, Li-Li Zou, Jia-Li Tan, Biao Dong, Zong-Gen Peng, Jian-Dong Jiang
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Treatment with direct-acting antivirals (DAAs) cures most patients infected with hepatitis C virus (HCV) in the real world. However, some patients, especially those with the underlying advanced liver disease, have a limited reduction of liver injury
Externí odkaz:
https://doaj.org/article/b94f0029016a49858255646f895beb5a
Publikováno v:
Viral Immunology. 35:597-608
Publikováno v:
Frontiers in Cardiovascular Medicine; 2024, p1-8, 8p
Autor:
Xiao Qin Lv, Qin Xiang, Yang Liu, Yue Wu, Min Cao, Zhong Hua Zhao, Hua Tang Zhang, Yu Wei Tang, Guo Qi Lai
Publikováno v:
Journal of Medical Virology. 92:3412-3419
High replication and mutation rates of hepatitis B virus (HBV) often lead to reduced or suppressed hepatitis B e antigen expression. The most common mutations are genomic variations in the basal core promoter (BCP) and pre-core (PC) regions. However,
Autor:
Lihua Wang, Yongfeng Yang, Menghao Huang, Qiang Li, Hu Li, Zhou-Yi Wu, Jian-Dong Jiang, Jian-Rui Li, Xiao-Qin Lv, Rong Xue, Pei Lan, Zong-Gen Peng, Jin-Hua Chen, Limin Zhao, Junjun Cheng, Wen-Jing Li
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 9, Iss 4, Pp 769-781 (2019)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Bicyclol is a synthetic drug for hepatoprotection in clinic since 2004. Preliminary clinical observations suggest that bicyclol might be active against hepatitis C virus (HCV) with unknown mechanism. Here, we showed that bicyclol significantly inhibi
Publikováno v:
European Journal of Pharmacology. 853:111-120
Farnesoid X receptor (FXR) agonists play important regulatory roles in bile acid, lipid and glucose metabolism in vitro and in vivo. Thus, FXR agonists exhibit potential therapeutic effects on metabolism-related diseases that are associated with extr
Autor:
Xiaomei Zhang, Xiao‐qin Lv, Xiao‐yu Peng, Kaifeng Liu, Xueli Li, Fang Lv, Lin Liu, Xiao He, Yu Pan, Liping Wang, Li Wang
Publikováno v:
Journal of Cellular Physiology. 234:15537-15547
Polycystic ovary syndrome (PCOS) is one of the most prevalent reproductive disorders in women worldwide. Despite rigorous research, the exact molecular mechanism that governs PCOS pathogenesis remains unclear. To investigate the potential roles of ci
Autor:
Hu Li, Pei Lan, Xiao-Qin Lv, Menghao Huang, Zhou-Yi Wu, Zong-Gen Peng, Rong Xue, Yongfeng Yang, Jin-Hua Chen, Wen-Jing Li, Limin Zhao, Junjun Cheng, Jian-Rui Li, Qiang Li, Lihua Wang, Jian-Dong Jiang
Publikováno v:
Acta Pharmaceutica Sinica B. 10:195-196